Advertisement
Screener

LianBio (LIANY) Increase (Decrease) in Other Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

LianBio Increase (Decrease) in Other Current Liabilities

LianBio (LIANY) reported Increase (Decrease) in Other Current Liabilities of $1.19 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2023-11-13

  • LianBio increase (decrease) in other current liabilities for the quarter ending 2023-09-30 was $913.00K.
  • LianBio increase (decrease) in other current liabilities for the quarter ending 2023-06-30 was -$1.22M.
  • LianBio increase (decrease) in other current liabilities for the quarter ending 2023-03-31 was $1.50M, a 1188.79% increase year-over-year.
  • LianBio increase (decrease) in other current liabilities for the quarter ending 2022-12-31 was $151.00K.
  • LianBio increase (decrease) in other current liabilities for fiscal 2022 was -$97.00K, a 113.25% decline from fiscal 2021.
  • LianBio increase (decrease) in other current liabilities for fiscal 2021 was $732.00K, a 95.20% increase from fiscal 2020.
  • LianBio increase (decrease) in other current liabilities for fiscal 2020 was $375.00K.
Period endIncrease (Decrease) in Other Current Liabilities 3 monthIncrease (Decrease) in Other Current Liabilities 6 monthIncrease (Decrease) in Other Current Liabilities 9 monthIncrease (Decrease) in Other Current Liabilities 12 month
2023-09-30$913.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$309.00K
derived: sum of 2 quarters · filed 2023-11-13
$1.19M
10-Q · filed 2023-11-13
$1.34M
derived: sum of 4 quarters · filed 2023-11-13
2023-06-30-$1.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$273.00K
10-Q · filed 2023-08-14
$424.00K
derived: sum of 3 quarters · filed 2023-08-14
$126.00K
derived: sum of 4 quarters · filed 2023-11-13
2023-03-31$1.50M
10-Q · filed 2023-05-11
$1.65M
derived: sum of 2 quarters · filed 2023-05-11
$1.35M
derived: sum of 3 quarters · filed 2023-11-13
$1.28M
derived: sum of 4 quarters · filed 2023-11-13
2022-12-31$151.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$147.00K
derived: sum of 2 quarters · filed 2023-11-13
-$213.00K
derived: sum of 3 quarters · filed 2023-11-13
-$97.00K
10-K · filed 2023-03-28
2022-09-30-$298.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$364.00K
derived: sum of 2 quarters · filed 2023-11-13
-$248.00K
10-Q · filed 2023-11-13
-$950.00K
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$66.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$50.00K
10-Q · filed 2023-08-14
-$652.00K
derived: sum of 3 quarters · filed 2023-08-14
-$922.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$116.00K
10-Q · filed 2023-05-11
-$586.00K
derived: sum of 2 quarters · filed 2023-05-11
-$856.00K
derived: sum of 3 quarters · filed 2023-05-11
-$81.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$702.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$972.00K
derived: sum of 2 quarters · filed 2023-03-28
-$197.00K
derived: sum of 3 quarters · filed 2023-03-28
$732.00K
10-K · filed 2023-03-28
2021-09-30-$270.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$505.00K
derived: sum of 2 quarters · filed 2022-11-10
$1.43M
10-Q · filed 2022-11-10
$1.85M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$775.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$1.70M
10-Q · filed 2022-08-11
$2.12M
derived: sum of 3 quarters · filed 2022-08-11
2021-03-31$929.00K
10-Q · filed 2022-05-12
$1.34M
derived: sum of 2 quarters · filed 2022-05-12
2020-12-31$416.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31
$375.00K
10-K · filed 2022-03-31
2020-09-30-$41.00K
10-Q/A · filed 2022-01-10